36 Recruiting Malignant Neoplasm Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Top Interventions for Malignant Neoplasm
Related Conditions
Top Recruiting Malignant Neoplasm Studies
Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔Reproductive Health Program in Patients With Cancer
📍 Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro — Jonesboro, Arkansas
View Study & Checklist ➔rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer
📍 Helen F Graham Cancer Center — Newark, Delaware
View Study & Checklist ➔Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies
📍 University of California at Los Angeles (UCLA ) — Los Angeles, California
View Study & Checklist ➔HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Molecular Genetics Studies of Cancer Patients and Their Relatives
📍 Valleywise Comprehensive Health Center - Phoenix — Phoenix, Arizona
View Study & Checklist ➔Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
📍 Jonsson Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
📍 Ocean Medical Center — Brick, New Jersey
View Study & Checklist ➔Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
📍 University of New Mexico Comprehensive Cancer Center — Albuquerque, New Mexico
View Study & Checklist ➔A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
📍 Rutgers Cancer Institute of New Jersey ( Site 0052) — New Brunswick, New Jersey
View Study & Checklist ➔A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
📍 University of Iowa Hospitals ( Site 4017) — Iowa City, Iowa
View Study & Checklist ➔KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
📍 Clermont Oncology Center ( Site 0041) — Clermont, Florida
View Study & Checklist ➔Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
📍 NEXT Oncology ( Site 0151) — San Antonio, Texas
View Study & Checklist ➔A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
📍 Alaska Womens Cancer Care ( Site 0037) — Anchorage, Alaska
View Study & Checklist ➔A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
📍 Childrens Hospital Los Angeles ( Site 3006) — Los Angeles, California
View Study & Checklist ➔